Pricing Log in Create free account
Friday 6 November 2026 Export HCSG’s income statement to Excel — free account

Healthcare Services Group, Inc.

HCSG Healthcare Medical Care Facilities

Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024.

Revenue
+3.29%
EPS
−37.3%
Free cash flow
−59.8%

Quarter to September 2026, against a year earlier

25.13 1.41 −5.31%
Market cap
$1.8B
P/E
16.6×
Fwd P/E
18.6×
Dividend yield
—
F-score
8/9
Altman Z
6.55
Beneish M
−3.09
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 3.83
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — 4 — — — — — 1 — 1 —
Insider Ownership 2.08%

Capital & Financial Ratios $m

Size
Market Cap 1,790.00
Revenue ttm 1,879.86
Net income ttm 104.88
Free cash flow ttm 106.86
Net debt Q (204.30)
Valuation
P/E 16.64
Forward P/E 18.60
Price / sales 0.91
Forward P/S Powerpack
Price / FCF 15.99
Price / book 3.22
Financial health
Current ratio Q 2.82 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q 100.43
Growth
Revenue growth Q +3.29% (above 0%: growing)
Operating income growth Q −30.37% (below 0%: shrinking)
EPS, this year +21.54% (at or above 15%: strong)
EPS, next year A −6.21% (below 0%: weak)
Revenue, next year A +5.81%
EPS, past 5 yrs −9.31% (below 0%: weak)
EPS, next 5 yrs A +9.51%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.8×, against a ten-year median of 0.9×; over the ten years it ranged from 0.3× in 2024 to 2.3× in 2017.
P/E against its own 10 years 4.40%
10-year low 10-year high
P/S against its own 10 years 48.70%
10-year low 10-year high
P/B against its own 10 years 45.87%
10-year low 10-year high
EV/Sales against its own 10 years 47.41%
10-year low 10-year high
EV/FCF against its own 10 years 31.13%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—
Growth, 2016–24
−100.0%/yr
  1. 0.73 ’16
  2. 0.75 ’17 +3
  3. 0.77 ’18 +3
  4. 0.79 ’19 +3
  5. 0.81 ’20 +3
  6. 0.83 ’21 +2
  7. 0.85 ’22 +2
  8. 0.00 ’23 −100
  9. 0.00 ’24
paid change on the year, %

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 147 136 204 204
Receivables 384 382 335 334
Inventory 18 17 17 16
Other — — — —
572 557 576 583
2023 2024 2025 Q'26
Payables 83 81 77 92
ST’ Debt 25 — — —
Other — — — —
217 193 170 206

Compound Annual Growth %

10y 5y 3y
Sales 2.49% 0.86% 2.82%
Cash Flow 8.63% (7.77%) 0.00%
Earnings 0.18% (9.76%) 19.92%
Book Value 5.58% 1.21% 6.85%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.22 Actual 0.36

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.23 0.44 Beat by 0.21
Q1 FY26 0.22 0.37 Beat by 0.15
Q2 FY26 0.20 0.32 Beat by 0.12
Q3 FY26 0.22 0.36 Beat by 0.14
Q4 FY26 0.27 — Reports 10 February 2027

EPS $

Mar Jun Sep Dec Year
’26 0.37 0.32 0.36 — —
’25 0.23 (0.44) 0.59 0.44 0.81
’24 0.21 (0.02) 0.19 0.16 0.53
’23 0.17 0.12 (0.07) 0.31 0.52
’22 0.15 0.09 0.00 0.22 0.47
’21 0.33 0.13 0.13 0.07 0.61
’20 0.27 0.31 0.37 0.37 1.32
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 463 471 480 — —
’25 448 458 464 467 1,837
’24 423 426 428 438 1,716
’23 417 419 411 424 1,671
’22 427 425 414 424 1,690
’21 408 398 416 420 1,642
’20 449 452 436 423 1,760
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 44 22 30 — —
’25 28 29 71 17 145
’24 (26) 16 4 36 31
’23 (16) 7 3 49 43
’22 (30) 9 (10) 23 (8)
’21 4 25 (23) 31 37
’20 13 80 49 76 217
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 42 20 28 — —
’25 26 27 70 16 139
’24 (28) 15 3 35 25
’23 (17) 6 1 48 38
’22 (31) 8 (11) 22 (13)
’21 3 24 (25) 30 32
’20 12 79 48 74 213
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 1,563 1,861 2,003 1,841 1,760 1,642 1,690 1,671 1,716 1,837 1,880 +1.8% 1,944 2,158 2,283 +7.5%
Gross margin, % 14.28 13.47 11.71 12.38 15.22 14.04 11.44 12.85 13.29 13.03 16.12 (1.3) pt
EBT 120 133 100 85 129 66 45 53 53 68 128 (6.2%)
EBT margin, % 7.70 7.14 4.99 4.62 7.34 3.99 2.64 3.17 3.09 3.69 6.80 (4.0) pt
Net income 77 88 84 65 99 49 34 38 39 59 105 (3.0%)
Per share, $
Per share, $ Revenue 21.48 25.37 27.06 24.75 23.57 21.95 22.74 22.50 23.26 25.38 27.64 +1.9%
Earnings 1.06 1.20 1.13 0.87 1.32 0.61 0.47 0.52 0.54 0.82 1.51 (2.8%)
Cash flow 0.57 0.10 1.08 1.26 2.91 0.50 (0.11) 0.59 0.42 2.00 1.66 +15.0%
Capex (0.07) (0.07) (0.06) (0.06) (0.05) (0.07) (0.06) (0.07) (0.08) (0.08) (0.09) +1.2%
Free cash flow 0.50 0.04 1.02 1.20 2.85 0.42 (0.17) 0.51 0.33 1.92 1.57 +16.2%
Book value 4.66 5.45 5.96 6.19 6.43 6.05 5.63 6.15 6.78 7.05 7.81 +4.7%
Shares, m 73 73 74 74 75 75 74 74 74 72 70 (0.1%)
Valuation, ×
Valuation, × P/E 36.09 42.99 35.53 28.28 21.29 27.15 26.92 20.08 21.52 23.32 16.64 28.3
P/S 1.80 2.03 1.48 0.98 1.19 0.81 0.55 0.47 0.50 0.75 0.91 1.1
P/B 8.29 9.46 6.75 3.93 4.37 2.94 2.22 1.73 1.71 2.71 3.22 4.4
EV/Sales 1.74 2.01 1.45 0.92 1.05 0.70 0.49 0.40 0.44 0.66 0.81 1.0
EV/FCF 75.02 1,453.52 38.31 19.02 8.63 36.43 (64.13) 17.48 30.24 8.65 14.31 162.3
Cash, $m
Cash, $m Operating cash flow 41 8 80 94 217 37 (8) 43 31 145 113 +14.9%
Capex (5) (5) (4) (4) (4) (5) (5) (5) (6) (6) (6) +1.1%
Free cash flow 36 3 76 89 213 32 (13) 38 25 139 107 +16.1%
Balance, $m
Balance, $m Working capital 314 343 345 367 410 355 320 355 364 406 376 +2.9%
Net debt (92) (47) (72) (108) (259) (179) (96) (122) (136) (204) (204) +9.3%
Shareholders’ equity 339 400 441 460 480 453 418 457 500 510 531 +4.7%
Returns, %
Returns, % ROA 15.34 14.65 12.21 9.13 13.09 6.21 4.57 5.08 4.95 7.40 12.68 (7.9) pt
ROIC 29.76 21.96 16.60 13.82 33.08 13.11 10.29 8.97 7.73 9.90 21.75 (19.9) pt
ROE 24.37 23.88 19.87 14.33 20.98 10.40 7.86 8.77 8.25 11.69 20.41 (12.7) pt
People
People Employees 48,900 55,000 55,000 51,000 44,200 39,200 35,700 33,400 35,300 36,000 — (3.3%)
Revenue/emp, $m 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.05 — +5.3%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Healthcare Services Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −21.11% (below 0%: shrinking) 32.08% 10.27% Compare
ASTH Astrana Health, Inc. $2.0B 46.8× 25.9× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
AMN AMN Healthcare Services Inc $1.9B 17.4× 25.4× +2.29% (above 0%: growing) n/m −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
ARDT Ardent Health, Inc. $1.8B 15.2× 12.8× +3.05% (above 0%: growing) n/m −23.49% (below 0%: shrinking) 100.00% 0.00% Compare
HCSG Healthcare Services Group, Inc. $1.8B 16.6× 18.6× +3.29% (above 0%: growing) −37.29% (below 0%: shrinking) −59.81% (below 0%: shrinking) 16.76% 6.66%
SNDA Sonida Senior Living, Inc. $1.8B — (loss-making) — (loss-making) +114.40% (above 0%: growing) n/m +360.11% (above 0%: growing) 35.68% (9.27%) Compare
AGL Agilon Health, Inc. $1.6B — (loss-making) — (loss-making) +5.86% (above 0%: growing) n/m +234.38% (above 0%: growing) 0.00% 1.59% Compare
PNTG The Pennant Group, Inc. $1.5B 37.3× 36.7× +31.96% (above 0%: growing) +55.56% (above 0%: growing) −3.19% (below 0%: shrinking) 13.34% 5.46% Compare
NUTX Nutex Health Inc. $1.4B 7.4× 7.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
Median of peers $1.8B 19.3× 22.9× +6.44% +55.56% −12.15% 31.33% 3.77%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 15 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 4.73m 12.21m 74.00
2024 4.68m 5.89m 45.00
2023 4.56m 3.34m 40.00
2022 4.41m 2.45m 47.00
2021 4.41m 1.42m 65.00

Ownership

Directors and executive officers, together 2.90%
BlackRock, Inc.3 16.20%
Mackenzie Financial Corp.3 5.10%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Healthcare Services Group, Inc. (HCSG) Latest News

28 Oct

Impact 4 · · Zacks

26 Oct

Impact 4 · · Zacks
Impact 4 · · Zacks

23 Oct

Impact 3 · · Zacks
Impact 3 · · Zacks

22 Oct

Impact 4 · · Simply Wall St.

21 Oct

Impact 4 · · The Motley Fool
Impact 4 · · Moby
Impact 4 · · The Motley Fool transcript
Impact 4 · · MarketBeat transcript
Impact 4 · · Business Wire
Impact 3 · · Zacks
Impact 3 · · Associated Press earnings

15 Oct

Impact 3 · · Zacks

7 Oct

Impact 4 · · Business Wire

29 Sep

Impact 3 ·

23 Sep

Impact 3 · · Zacks

9 Sep

Impact 3 ·

22 Jul

Impact 4 ·
Impact 3 · · Moby transcript
Impact 3 · · MarketBeat transcript
Impact 3 ·

25 Apr

Impact 4 · · Simply Wall St.

23 Apr

Impact 4 · · Moby
Impact 4 · · GuruFocus.com
Impact 3 · · MarketBeat

22 Apr

Impact 4 · · InvestorsHub
Impact 4 · · Zacks
Impact 4 · · Business Wire

12 Feb

Impact 3 · · Simply Wall St.
stockrow.com/HCSG · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com